JBIO

Conviction 56HealthcareScan · Mon, Aug 10, 2026

JBIO$21.75-0.96%

ResistanceSupportVol 14

Vol MA14 867.11K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Jade Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.jadebiosciences.com ↗

Price21.75

Change-0.96%

Gap-0.73%

Rel volume1.36×

Avg volume882.14K

Avg $ vol18.29M

SMA 2020.56

SMA 5019.78

SMA 20016.87

Price vs 50+9.98%

Price vs 200+28.96%

MA stackbullish

50/200 cross—

Supertrendup · 17.97

RSI (14)57

MACD hist0.22

MACD crossbull · 3d

Stoch %K / %D72 / 77

ADX (14)15

+DI / −DI19 / 15

RSI divergence—

MACD divergenceBullish

ATR %+7.01%

ADR %7.20%

52w high26.85

52w low6.77

From 52w high-18.99%

Above 52w low+221.27%

New 52w highNo

SqueezeOn · 5d

Bollinger width18.69%

%B0.81

Donchian pos71.97%

Donchian high23.00

Donchian low18.54

AVWAP (52w high)20.18

vs AVWAP high+7.80%

AVWAP (52w low)17.92

vs AVWAP low+21.38%

OBV trendFlat

Chaikin MF (20)-0.00

Today vs 20d1.36×

Avg vol (14d)867.11K

Avg vol (20d)882.14K

Avg $ vol (20d)18.29M

Market cap1.38B

RS 3m (vs SPY)-15.03%

RS 6m (vs SPY)+38.49%

RS line new highNo

Trend template7/8

Technical rank81.6

1 week+13.58%

1 month+3.82%

3 months-15.73%

6 months+41.97%

1 year+197.13%

YTD+53.60%

P/E-10.86

P/B3.14

P/S—

P/FCF-14.58

EPS-3.19

Div yield—

ROE-28.96%

ROA-26.99%

Debt/Eq—

Current14.93

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-82.99%

Price target50.50

Target upside132.18%

Analyst ratingBuy

Institutional90.78%

Ent. value1.28B

Revenue—

Net income-55.77M

Gross profit—

Free cash flow-94.89M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out49.36M

Employees55

ListedTue, Apr 29, 2025

Free float41.37M

Float %83.9%

Short interest7.53M

Days to cover7.2d

Short volume61.3%

Squeeze score81 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.57 vs −$0.52

Last surprise-9.6% miss

Setup gradeC

Conviction56 / 100

Pattern quality—

Tech rank81.6 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance23.43

Support18.55

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in JBIO

All disclosures →

No recent disclosed trades by Congress in JBIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in JBIO

No recent insider (Form 4) filings in JBIO. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in JBIO · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.